These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 20392387)
1. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child. Habib A; Pasha W; Raza N J Coll Physicians Surg Pak; 2010 Mar; 20(3):205-7. PubMed ID: 20392387 [TBL] [Abstract][Full Text] [Related]
2. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Stella M; Clemente A; Bollero D; Risso D; Dalmasso P Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410 [TBL] [Abstract][Full Text] [Related]
5. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]
6. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases]. Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. French LE; Trent JT; Kerdel FA Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917 [TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options. Teo L; Tay YK; Liu TT; Kwok C Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081 [TBL] [Abstract][Full Text] [Related]
9. Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality. Aires DJ; Fraga G; Korentager R; Richie CP; Aggarwal S; Wick J; Liu DY J Drugs Dermatol; 2013 Jun; 12(6):679-84. PubMed ID: 23839186 [TBL] [Abstract][Full Text] [Related]
10. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis. Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Khalili B; Bahna SL Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]. Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835 [TBL] [Abstract][Full Text] [Related]
13. IVIG for the treatment of toxic epidermal necrolysis. Mittmann N; Chan BC; Knowles S; Shear NH Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314 [TBL] [Abstract][Full Text] [Related]
14. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829 [TBL] [Abstract][Full Text] [Related]
15. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214 [TBL] [Abstract][Full Text] [Related]
16. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Koh MJ; Tay YK Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732 [TBL] [Abstract][Full Text] [Related]
17. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits. Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280 [TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis. Ririe MR; Blaylock RC; Morris SE; Jung JY J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282 [TBL] [Abstract][Full Text] [Related]